First Trust Advisors
DICE

First Trust Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

First Trust Advisors’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28,677
Closed -$1.33M – 2538
2023
Q2 		$1.33M Buy
+28,677
New +$991K ﹤0.01% 1888

First Trust Advisors's DICE Position: Q3 2023 in Review

First Trust Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 28,677 shares — an estimated $1.33M sold.

First Trust Advisors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.33M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • First Trust Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • First Trust Advisors sold 28,677 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.33M.
  • First Trust Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • First Trust Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $1.33M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on First Trust Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.